Comparison of four-times-a-day and twice-a-day dosing regimens in subjects requiring 1200 μg or less of budesonide to control mild to moderate asthma
- 30 September 1995
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 89 (8) , 537-543
- https://doi.org/10.1016/0954-6111(95)90154-x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Four-times-a-day Dosing Frequency Is Better than a Twice-a-day Regimen in Subjects Requiring a High-dose Inhaled Steroid, Budesonide, to Control Moderate to Severe AsthmaAmerican Review of Respiratory Disease, 1989
- New inhalation devicesEuropean Respiratory Journal, 1988
- CONCENTRATED AEROSOL FORMULATIONS IN ASTHMAThe Lancet, 1983
- Reference Values of the Provocative Concentrations of Methacholine that Cause 6% and 20% Changes in Forced Expiratory Volume in One Second in a Normal Population1–3American Review of Respiratory Disease, 1983
- Comparison of twice daily administration of a new corticosteroid budesonide with beclomethasone dipropionate four times daily in the treatment of chronic asthmaRespiratory Medicine, 1982
- Asthma treatment with a new corticosteroid aerosol, budesonide, administered twice daily by spacer inhalerArchives of Disease in Childhood, 1982
- Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonideJournal of Allergy and Clinical Immunology, 1982
- Bronchial reactivity to inhaled histamine: a method and clinical surveyClinical and Experimental Allergy, 1977